
NewsMachine Learning
FDA Approves Eli Lilly’s GLP-1 Pill
via WiredEmily Mullin
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Continue reading on Wired
Opens in a new tab
2 views



